THIS STUDY concerns the effect of cardiac catheterization and angiocardiography on the serum glutamic oxaloacetic transaminase (SGO-T). It was prompted by the finding of an elevation of this enzyme in a patient whose heart wall was inadvertently punctured during transseptal left heart catheterization and in whom the possibility of traumatic myocardial infaretion was entertained.
To our knowledge, only one study of the effect of cardiac catheterization on the serum transaminase has been published. ' Abnormal elevation of SGO-T was reported by this group in two of 25 patients studied.
Material and Methods
The subjects were 25 patients undergoing cardiac catheterization and 21 having angiocardiography at the University of Oregon Medical School. Patients receiving anticoagulants or exhibiting clinical evidence of liver disease, congestive heart failure, or active carditis, and those undergoing combined cardiac catheterization and angiocardiography were excluded. No other criterion for selection was used. All were hospitalized for the entire period of the study with the exception of three who were followed as outpatients. In 70 normal adults studied in our laboratory, the SGO-T activity ranged from 9 to 42 units, with a mean of 18.1 ± 6.9 units. Values between 43 and 50 units were considered borderline and above 50 units abnormal for this study.
Results
The SGO-T responses* to cardiac catheterization and angiocardiography were similar and divisible into five patterns: 5. Abnormal SGO-T elevation prior to procedure: SGO-T was abnormally elevated in the control samples of five patients undergoing cardiac catheterization and three having angiocardiography ( fig. 1D) . Peak values ranged from 57 to 91 units. Usually this elevation was sustained; further increases followed the procedure in three cases. The subjects were all adults with long-standing heart disease (rheumatic heart disease in seven and atrial septal defect in one). Although none was in overt heart failure at the time of the study, all had been in failure in the past.
Discussion
The foregoing data indicate that SGO-T may be abnormally elevated following cardiac catheterization or angiocardiography. The incidence* of elevation was higher in the former (55 per cent) than the latter (39 per cent); this difference was not statistically significant. Although the elevations were modest in most cases, some were in the range seen with myocardial infaretion.
There was no correlation between enzyme level and cardiac lesion, type or duration of procedure, trauma, exercise, amount of dye or contrast agent used, or number, pressure, duration and site of injections of contrast agent. Of the six complications observed, only in the patient who had thrombophlebitis and myositis was a correlation noted. The SGO-T rise paralleled the development of this complication and was probably due to skeletal muscle involvement, since thrombophlebitis per se is not a cause of SGO-T elevation.5
The etiology of abnormal enzyme elevation is not clear. Whether it is cardiac or extracardiac in origin cannot be determined from this study. It cannot be attributed to Coomassie blue or the contrast substance, since a significant number of patients receiving these agents did not show any elevation of the en-*Patients with abnormal SGO-T elevation prior to the procedure were excluded. 
